Despite both PHD1 and PHD2 had no obvious change between tumor and normal tissue; further statistic investigation presented a reverse correlation between the tumor PHD1 level and recurrence of HCC patients (Seen in Supplementary Figure 4). This evidence concerns the gene EGLN2 and hepatocellular carcinoma.